You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指半日收報22,162點 升90點; 恆生科技指數半日收報4,777點 升81點 百度集團-SW升逾6% 康寧傑瑞製藥、沛嘉醫療、百融雲-W、諾輝健康、美圖創新高
恆指半日收22,162點,升90點或0.4%。恆生科技指數報4,777點,升81點或1.7%。國指升35點或0.5%,報7,596點。 活躍重磅股表現: 友邦(01299.HK) 收85.55元,下跌1.6%; 騰訊(00700.HK) 收390.6元,上升1.5%; 港交所(00388.HK) 收355元,上升0.7%; 阿里巴巴(09988.HK) 收110.6元,上升0.5%; 美團(03690.HK) 收179.7元,下跌0.2%; 平安(02318.HK) 收61.55元,下跌0.2%; 異動恆指及國指成份股: 百度集團-SW(09888.HK) 收154.3元,上升6.9%; 舜宇(02382.HK) 收114.5元,上升4.9%; 碧桂園服務(06098.HK) 收20.8元,下跌4.1%; 中生製藥(01177.HK) 收4.79元,上升4.1%; 聯通(00762.HK) 收5.74元,上升3.6%; 藥明生物(02269.HK) 收69.4元,上升3.5%; 小米集團(01810.HK) 收13.96元,上升3.4%; 翰森製藥(03692.HK) 收16.84元,上升3.3%; 金沙(01928.HK) 收29元,下跌3.2%; 華潤萬象生活(01209.HK) 收44.15元,下跌3.1%; 異動綜合中小型股: 永泰生物-B(06978.HK) 收6.79元,上升19.8%; 祖龍娛樂(09990.HK) 收5.22元,上升17%; 香港航天科技(01725.HK) 收6.89元,上升15.2%; 康寧傑瑞製藥(09966.HK) 收16.7元,上升12.5%,創新高; 騰盛博藥-B(02137.HK) 收13.08元,上升11.6%; 沛嘉醫療(09996.HK) 收13.82元,上升10.7%,創新高; 創新奇智(02121.HK) 收21.65元,下跌10.7%; 信利國際(00732.HK) 收1.57元,上升10.6%; 百融雲-W(06608.HK) 收13.42元,上升9.6%,創新高; 諾輝健康(06606.HK) 收36.15元,上升9.5%,創新高; 美圖(01357.HK) 收2.5元,上升7.3%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account